Clinical Decision Support System (CDSS) Market Size To Reach USD 2.41 Billion By 2027 CAGR of 9.5%

Clinical Decision Support System (CDSS)

The global clinical decision support system (CDSS) market is expected to reach USD 2.41 Billion by 2027, according to a new report by Reports and Data. The increasing incidences of chronic diseases across different parts of the globe would impact the clinical decision support system (CDSS) market positively. The increasing instances of chronic disorder would lead to an increased number of patients entering the hospitals, which would increase the amount of data at the hospitals’ end. Thus, a precise and error-free tool for handling the data would be an inevitable need, where CDSS would come into play. For instance, Machine learning has operated a CDS device at the University of Pennsylvania that reduces the time for sepsis diagnosis by 12 hours, which could be the difference between life and death for many people.  For research, the algorithm used data from more than 160,000 patients and was validated on a survey of another 10,000 people.

The role of government plays an important in bringing any new system or technology in the culture of the healthcare industry. A clinical decision support system is an expensive phenomenon, hence an initial stage of the launch of this system, the financial support, and awareness spread by the government would play an essential role in this industry. This would ultimately improve the healthcare condition of the respective country. For instance, initiated in November 2015, China’s 13th Five-Year Plan (FYP) focused on transforming the healthcare services in the region. State spending on healthcare in China increased from 15% in 1999 to 30% in 2013, and out-of-pocket expenditures dropped from 60% to 34%. In China, IT is being used to revolutionize hospitals, drug development, and delivery. In China, the use of mobile health technology (mHealth) is growing to boost communication with rural/remote areas.

To understand how our report can bring difference to your business strategy, Ask for a brochure

However, the cost of implementing a clinical decision support system is not pocket friendly for all hospital and clinical centers and may hamper the market growth in the upcoming years. Such systems ‘ servicing and software upgrading costs can sometimes be more than the real product size.

COVID-19 Impact

The clinical decision support system aids clinicians in diagnosing and treating COVID-19. It is of immense importance to hospital systems, emergency care companies, emergency room providers, and telehealth service providers dynamically coming across COVID-19 patients all across the globe.  CDSS helps to associate of healthcare industry experts from major health systems, medical societies, and evidence-based content vendors, among others, to swiftly provide effective clinical pathways for COVID-19. These pathways assist in streamlining the service provider’s workflow by organizing clinical documentation with each collaboration and offering the most current diagnosis and appropriate treatment information obtainable based on the patient’s showing symptoms, comorbidity, and severity.

Market Dynamics:

Increasing development of on-demand, digitally enabled, and seamlessly connected clinician-patient interactions to manage patient base is expected to drive pharma and healthcare market in the coming years. After the COVID-19 outbreak there has been a number of foundational shifts in the healthcare system. Some of the examples include increasing consumer involvement in health care decision-making, the rapid adoption of virtual health & other digital innovations, increasing focus on utilization of interoperable data & data analytics, and increased public-private collaborations in therapeutics and vaccine development. The increased public-private collaborations for vaccine development has arisen due to high pressure of regional governments. Health care providers, and other stakeholders have invested heavily to quickly pivot, adapt, and innovate therapeutics.

Surging demands and transition to patient-centric care delivery across geographies will change pharma and healthcare market trends through 2027.

Competitive Outlook:

The report focuses on current and emerging trends in the healthcare industry such as incorporation of IoT and Machine Learning to enhance efficiency of medical products. Top companies in the market are focusing on R&D activities to expand their product offerings and cater to unmet medical needs.

Reports and Data offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough, request for custom research report

To Top

Pin It on Pinterest

Share This